The Body’s Natural Cannabinoid System
Endocannabinoids in the body are degraded by fatty acid amide hydrolase (FAAH). Cannabidiol (CBD), another component of medical marijuana, inhibits FAAH, allowing more naturally-occurring endocannabinoids to remain active in the body.
Imbalances of the endocannabinoid system are associated with many diseases, explaining why medical marijuana has a beneficial effect on a variety of medical conditions.
Current research on the endocannabinoid system is seeking new treatments for autoimmune, inflammatory, and neurodegenerative diseases, as well as non-addictive ways to relieve pain.
The delta9-Tetrahydrocannabinol (THC) in marijuana resembles the endocannabinoid molecules, anandamide and 2-Ag, manufactured by the human body. THC binds with CB1 and CB2 receptors to replace or augment naturally-occurring endocannabinoid.